DENVER — The following statement was issued by Lucy Westerfield, deputy executive director of Patients For Affordable Drugs Now, following the Colorado state legislature’s vote to pass SB 21-175, a bill that establishes a prescription drug affordability board designed to deliver relief to Coloradans suffering from high drug prices:
“The passage of SB 21-175 is a huge win for Colorado patients who have struggled with outrageous prescription drug prices for far too long. We are grateful to the Colorado state legislature for standing with patients and passing this groundbreaking bill to establish a prescription drug affordability board and meaningfully lower drug prices. We look forward to Governor Polis signing this bill into law.”
Background:
###
AUGUSTA — The following statement was issued by Lucy Westerfield, deputy executive director of Patients For Affordable Drugs Now, leading up to the Maine Senate and House votes on the Making Health Care Work for Mainepackage to lower drug prices. This statement follows the Health Coverage, Insurance, and Financial Services Committee votes last week to move the package to the floor of both chambers:
“Maine legislators have a clear choice to make when voting on the Making Health Care Work for Maine package — they can vote in favor of Maine patients who are struggling to afford high prescription drug prices, or they can vote in favor of Big Pharma’s interests.
“In order to protect Mainers from pharmaceutical price gouging and unnecessary price increases, the legislature must pass the strongest versions of LD 675 and LD 1117 along with the remainder of the package. That’s why next week, P4ADNow is launching a tool to mobilize Mainers to call on their legislators to support the full package. Patients need meaningful prescription drug price relief now.”
Background:
###
KANSAS — Patients For Affordable Drugs Now kicks off a campaign today thanking Rep. Sharice Davids (KS-03) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Kansans. The campaign includes digital ads as well as grassroots advocacy, in which constituents will contact Rep. Davids to thank her for fighting for patients. The campaign comes after Big Pharma launched a campaign loaded with lies, pressuring Rep. Davids not to support H.R. 3.
“Big Pharma is trying to get Rep. Davids to bow to its power with lies and fear-mongering. But she is standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Rep. Davids’ leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign launches with an ad highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ad will run on digital platforms in Kansas’ third district.
You can watch the ad here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The Kansas campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.
###
NEW HAMPSHIRE — Patients For Affordable Drugs Now kicks off a campaign today thanking Rep. Chris Pappas (NH-01) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Granite Staters. The campaign includes digital ads as well as grassroots advocacy, in which constituents will contact Rep. Pappas to thank him for fighting for patients. The campaign comes after Big Pharma launched attack ads loaded with lies, pressuring Rep. Pappas not to support H.R. 3.
“Big Pharma is trying to get Rep. Pappas to bow to its power with lies and fear-mongering. But he is standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Rep. Pappas’s leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign launches with an ad highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ad will run on digital platforms in New Hampshire’s first district.
You can watch the ad here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The New Hampshire campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.
###
MAINE — Patients For Affordable Drugs Now kicks off a campaign today thanking Rep. Jared Golden (ME-02) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Mainers. The campaign includes digital ads and grassroots advocacy, in which constituents will contact Rep. Golden to thank him for fighting for patients. The campaign comes after Big Pharma launched attack ads loaded with lies, pressuring Rep. Golden not to support H.R. 3.
“Big Pharma is trying to get Rep. Golden to bow to its power with lies and fear-mongering. But he is standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Rep. Golden’s leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign launches with an ad highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ad will run on digital platforms in Maine’s second district.
You can watch the ad here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The Maine campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.
###
CALIFORNIA — Patients For Affordable Drugs Now kicks off a campaign today thanking Reps. Josh Harder (CA-10) and Mike Levin (CA-49) for supporting Medicare negotiation, and calling on Reps. Tony Cárdenas (CA-29), Lou Correa (CA-46), Scott Peters (CA-52), and Sara Jacobs (CA-53) to support swift passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate lower prices for Californians. The campaign includes digital ads as well as grassroots advocacy for constituents to contact the members in support of H.R. 3. The campaign comes after Big Pharma launched ads loaded with lies, attacking members for supporting the bill.
“Californians need Reps. Cárdenas, Correa, Peters, and Jacobs to follow Reps. Harder and Levin’s lead and push for passage of H.R. 3 to ensure we get affordable medicines we need now and innovation for the future,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “The choice is clear: You either stand with patients for lower prices or with pharma for higher prices. We need lower drug prices now.”
Digital ads will run in CA-10 and CA-49 thanking Reps. Harder and Levin for supporting Medicare negotiation. Digital ads will run in CA-29, CA-46, CA-52, and CA-53, urging Reps. Cárdenas, Correa, Peters, and Jacobs to stand with patients and push for passage of H.R. 3.
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching simultaneously in 42 House districts across 22 states and in D.C.
###
GEORGIA — Patients For Affordable Drugs Now kicks off a campaign today thanking Rep. Carolyn Bourdeaux (GA-07) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Georgians. The campaign includes TV and digital ads as well as grassroots advocacy, in which constituents will contact Rep. Bourdeaux to thank her for fighting for patients. The campaign comes after Big Pharma launched attack ads loaded with lies, pressuring Rep. Bourdeaux not to support H.R. 3.
“Big Pharma is trying to get Rep. Bourdeaux to bow to its power with lies and fear-mongering. But she is standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Rep. Bourdeaux’s leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign includes an ad highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ad will run on a combination of TV and digital platforms in Georgia’s seventh district.
You can watch the ad here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The Georgia campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.
###
VIRGINIA — Patients For Affordable Drugs Now kicks off a campaign today thanking Reps. Elaine Luria (VA-02) and Abigail Spanberger (VA-07) for supporting H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, a package of drug pricing reforms that includes allowing Medicare to negotiate for lower prices for Virginians. The campaign includes TV and digital ads as well as grassroots advocacy, in which constituents will contact Reps. Luria and Spanberger to thank them for fighting for patients. The campaign comes after Big Pharma launched attack ads loaded with lies, pressuring the representatives not to support H.R. 3.
“Big Pharma is trying to get Reps. Luria and Spanberger to bow to its power with lies and fear-mongering. But they are standing strong to win reforms that will lower the outrageous prices of prescription drugs,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Thanks to Reps. Luria and Spanberger’s leadership, we can pass H.R. 3 to ensure we get affordable medicines we need now and innovation for the future.”
The campaign features ads highlighting patient advocate Marcus LaCour, who lives with type 1 diabetes. The ads will run on a combination of TV and digital platforms in districts VA-02 and VA-07.
You can watch the ad in VA-02 here.
You can watch the ad in VA-07 here.
“I was diagnosed with type 1 diabetes at 15 years old. Because insulin is so expensive, I’ve had to skip and ration my doses. My wife has had to skip meals so that we could afford the insulin that I needed to survive,” LaCour, a Cincinnati husband, father, minister, and drug affordability advocate says in the video ad. “No family should have to make that decision. For millions of Americans, it’s serious enough that we need help.”
H.R. 3 was recently reintroduced in the House of Representatives. The chamber passed the bill in the 116th Congress. H.R. 3 is a comprehensive bill that will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.
The Virginia campaign is part of Patients For Affordable Drugs Now’s seven-figure national campaign launching in 42 House districts across 22 states and in D.C.
###